Degree of serotonin reuptake inhibition of antidepressants and ischemic risk
- 3 September 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 93 (10) , e1010-e1020
Abstract
Objective To assess whether use of antidepressants with strong inhibition of serotonin reuptake is associated with a decreased incidence of ischemic stroke and myocardial infarction (MI). Methods We conducted a cohort study using the UK Clinical Practice Research Datalink and considering new users of selective serotonin reuptake inhibitors (SSRIs) or third-generation antidepressants who were ≥18 years of age between 1995 and 2014. Using a nested case-control approach, we matched each case of a first ischemic stroke or MI identified during follow-up with up to 30 controls on age, sex, calendar time, and duration of follow-up. We estimated incidence rate ratios (RRs) and 95% confidence intervals (CIs) of each outcome associated with current use of strong compared with weak inhibitors of serotonin reuptake using conditional logistic regression. Results The cohort included 938,388 incident users of SSRIs (n = 868,755) or third-generation antidepressants (n = 69,633). Mean age at cohort entry was 46 years (64% women). During follow-up, 15,860 cases of ischemic stroke and 8,626 cases of MI were identified and matched to 473,712 and 258,022 controls, respectively. Compared with current use of weak inhibitors of serotonin reuptake, current use of strong inhibitors was associated with a decreased rate of ischemic stroke (RR 0.88, 95% CI 0.80–0.97), but the effect size was smaller in some sensitivity analyses. The rate of MI was similar between strong and weak inhibitors (RR 1.00, 95% CI 0.87–1.15). Conclusion Our large population-based study suggests that antidepressants strongly inhibiting serotonin reuptake may be associated with a small decrease in the rate of ischemic stroke.Keywords
This publication has 32 references indexed in Scilit:
- Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressantsBMJ Open, 2012
- Effects of Selective Serotonin Reuptake Inhibitors on Platelet FunctionDrugs & Aging, 2011
- Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health SurveyEuropean Heart Journal, 2010
- Validity of diagnostic coding within the General Practice Research Database: a systematic reviewBritish Journal of General Practice, 2010
- Validation and validity of diagnoses in the General Practice Research Database: a systematic reviewBritish Journal of Clinical Pharmacology, 2009
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims DataEpidemiology, 2009
- Effect of Selective Serotonin Reuptake Inhibitors on Platelet ActivationAmerican Journal of Cardiovascular Drugs, 2003
- Selective Serotonin Reuptake Inhibitors and the Risk of StrokeStroke, 2002
- The way I see it: House officers need formal career developmentBMJ, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002